• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Regulation of tissue factor and thrombomodulin expressions

Research Project

Project/Area Number 13671052
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionTokyo Medical and Dental University

Principal Investigator

KOYAMA Takatoshi  Tokyo Medical and Dental University, Graduate School of Health Sciences, Associate Prof., 大学院・保健衛生学研究科, 助教授 (20234916)

Co-Investigator(Kenkyū-buntansha) YAMAMOTO Keiko  Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Instructor, 生体材料工学研究科, 助手 (90147017)
Project Period (FY) 2001 – 2003
Keywordsthrombomodulin / tissue factor / gene transfer / plasmin inhibitor
Research Abstract

1) Expression of thrombomodulin (TM)
We have found that with the mutations at positions -133 and -33, the TM gene expression may be decreased, and the decreased TM expression could not efficiently inhibit the effects of thrombin. These mutations may cause hyper-coagulable states, and increase atheroscierogenesis, leading to thromboembolic disorders such' as coronary diseases.
Transferrin receptor-facilitated in vivo gene transfer to the inferior vena cava resulted in sufficient TM gene expression and subsequent maintenance of thromboresistance even after exposure to arterial pressure. Our results had implications for applying this technology to coronary bypass operations.
2) Expression of tissue factor (TF)
We eluted the adsorbed leukocytes from extracorporeal circuits used for 6 patients by washing with EDTA-HEPES buffer. The leukocytes, representing 5 to 10% of the circulating leukocytes, were collected. Most were neutrophils expressing CD 11 b antigens as high as those in circulation du … More ring cardiopulmonary bypass (CPB). Adsorbed monocytes expressed TF higher than those in circulation. These results indicated that extracorporeal circuits adsorb a large number of activated neutrophils and a small number of highly thrombogenic monocytes during their use. Furthermore, we found the involvement of two distinct mechanisms for the appearance of TF-bearing leukocytes responsible for promoting coagulation during and after CPB: the quick appearance being partly explained by the formation of leukocyte-platelet complex that occurs mainly in the pericardial cavity, and the slow appearance via transcriptional activation in monocytes. These results suggested that the reinfusion of the wound blood containing activated monocytes could produce a procoagulant state in the patient body. To reduce the likelihood of this harmful reaction, it might be of use to remove monocytes from the wound blood washed by a cell-saving device by using a leukocyte filter. Another study demonstrated that some protease inhibitors might act as stress and induced TF expression with direct phosphorylation of JNK and p38, followed by phosphorylation and activation of AP-1 in monocytic cells.
3) Abnormality of intracellular transport of proteins in cases of congenital protein deficiencies
We have carried out molecular analysis of American family members with congenital plasmin inhibitor (PI) deficiency, and detected a single thymine deletion at nucleotide position 332 in exon 5. This is the 5th case of PI deficiency in which the genetic abnormality was identified. We further found that the mutant PI was retained and underwent progressive degradation by proteasome within the cells, and was minimally excreted into the media. Less

  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] Tabuchi N: "Leukocyte adsorption to the surface of the extracorporeal circuit influences its biocompatibility."Artificial Organs. 27(6). 591-594 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohsawa M: "Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal kinase and p38."Thromb Res. 112(5/6). 313-320 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shibamiya A: "Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass."Thromb.Haemost.. (in press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 中原正子: "先天性プラスミンインヒビター欠損症:基礎と臨床"臨床血液. 44(3). 149-158 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 中原正子: "1塩基欠失による先天性プラスミンインヒビター欠乏症の解析"臨床血液. 45(1). 1-5 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 中澤文恵: "トロンボモジュリン遺伝子変異の解析"The Medical Test Journal. 871. 7 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakazawa F: "Characterization of thrombomodulin gene mutations of the 5'-regulatory region."Atherosclerosis. 164(2). 385-387 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshinaga H: "A single thymine nucleotide deletion responsible for congenital deficiency of plasmin inhibitor."Thromb.Haemost.. 88(1). 144-148 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki K: "Novel method for detection of ex vivo tumor necrosis factorα production by monocytes."J.Clin.Lab.Anal.. 16. 273-278 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 柴宮綾: "人工肺膜表面の吸着細胞から検討した人工回路の生体適合性"膜型肺. 25. 19-21 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 小山高敏: "100周年記念誌 血液分野 主要疾患の歴史 10)血栓症"日本内科学会雑誌. 91(7). 2120-2124 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Matsuda K: "Sensitive method for detection and semiquantification of Bence Jpnes protein by cellulose acetate membrane electrophoresis using colloidal silver staining."Clin.Chem.. 47(4). 763-766 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tabuchi N: "Remaining procoagulant property of wound blood washed by a cell-saving device."Ann.Thorac.Surg.. 71. 1749 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Madoiwa S: "Autoantibody against prothrombin aberrantly alters the proenzyme to facilitate formation of a complex with its physiological inhibitor antithrombin III without thrombin conversion."Blood. 97(12). 3783-3789 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 伊藤正男, 井村裕夫, 高久史麿 編: "医学書院 医学大辞典,血液凝固関連項目"医学書院,東京. (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koyama T: "Modern Trends in Skin Pharmacology : Molecular and Clinical Aspects"Anticoagulant effects of synthetic retinoids and activated vitamin D_3(1,25(OH)_2D_3) analogs. edited by Tsambaos D & Merk H.Parissianos Medical Publishers, Athens, Greece.. 189-215 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Matsuda K, Hiratsuka N, Koyama T, Kurihara Y, Hotta O, Itoh Y, Shiba K: "Sensitive method for detection and semiquantification of Bence Jones protein by cellulose acetate membrane electrophoresis using colloidal silver staining."Clin.Chem.. 47(4). 763-766 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tabuchi N, Koyama T, Shibamiya A, Sunamori M: "Remaining procoagulant property of wound blood washed by a cell-saving device."Ann.Thorac.Surg.. 71(5). 1749 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Madoiwa S, Nakamura Y, Mimuro J, Furusawa S, Koyama T, Sugo T, Matsuda M, Sakata Y: "Autoantibody against prothrombin aberrantly alters the proenzyme to facilitate formation of a complex with its physiological inhibitor antithrombin III without thrombin conversion."Blood. 97(12). 3783-3789 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koyama T, Ohsawa M, Nakazawa F, Shibamiya A: "Anticoagulant effects of synthetic retinoids and activated vitamin D3 (1,25(OH)_2D_3) analogs."Modem Trends in Skin Pharmacology: Molecular and Clinical Aspects, edited by Tsambaos D & Merk H.) (Parisians Medical Publishers, Athens, Greece). 189-215 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshinaga H, Nakahara M, Koyama T, Shibamiya A, Nakazawa, Miles LA, Hirosawa S, Aoki N: "A single thymine nucleotide deletion responsible for congenital deficiency of plasmin inhibitor."Thromb.Haemost.. 88(1). 144-148 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakazawa F, Koyama T, Shibamiya A, Hirosawa S: "Characterization of thrombomodulin gene mutations of the 5'-regulatory region."Atherosclerosis. 164(2). 385-387 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki K, Koyama T, Kobayashi S, Kobayashi K, Inagaki K, Abe Y, Kuriyama K, Shiba K: "Novel method for detection of ex vivo tumor necrosis factor a production by monocytes."J.Clin.Lab.Anal.. 16(6). 273-278 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tabuchi N, Shibamiya A, Koyama T, Fukuda T, van Oeveren W, Sunamori M: "Leukocyte adsorption to the surface of the extracorporeal circuit influences its biocompatibility."Artificial Organs. 27(6). 591-594 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ohsawa M, Koyama T, Nara N, Hirosawa S: "Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal kinase and p38."Thromb.Res.. 112(5/6. 313-320 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shibamiya A, Tabuchi N, Sunamori M, Chung J, Koyama T: "Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass."Thromb.Haemost.. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi